Buy Creon
Creon

3.75
Creon (Pancrelipase) is a combination of digestive enzymes used to help people who cannot digest food properly because their pancreas is not functioning correctly. it helps individuals absorb fats, proteins, and sugars from their diet. This replacement therapy is vital for maintaining nutrition and preventing digestive discomfort.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Active Ingredient(s)
Pancrelipase
Reference Brand
Creon
Manufacturer
Viatris
Product Form
Gastro-resistant capsules
Regulatory Classification
Rx
Primary Category
Digestive Support
Product Category
Alimentary Tract, Digestives, including enzymes
Pharmacological Class
Pancreatic Enzyme Replacement Therapy (PERT)
Manufacturer Description
Digestive enzymes used to help people whose bodies don't make enough naturally to digest food properly.
Mechanism of Action
Creon contains a mixture of enzymes normally produced by the pancreas. It works by breaking down fats, proteins, and sugars in food, allowing the body to absorb nutrients when the pancreas cannot produce enough enzymes itself.
Route of Administration
Oral
Onset Time
Starts working as soon as it reaches the stomach/intestine with food
Duration
For the duration of the meal digestion
Contraindications
Allergy to pork proteins, Acute pancreatitis flare-up
Severe Adverse Events
Fibrosing colonopathy (rare bowel scarring), Severe joint pain, Severe allergic reactions
Common Side Effects
Mild stomach pain, Nausea
Uncommon Side Effects
Bloating, Frequent bowel movements, Constipation
Drug Interactions
Acarbose, Iron supplements
Pregnancy Safety Warnings
Generally considered safe but must be supervised by a consultant.
Age Restrictions
Prescribed for both children and adults
Storage Guidelines
Keep container tightly closed. Store below 25°C.
Related Products
Nutrizym, Pancrease HL, Pancrex

Creon FAQ

Can I take Creon if I am pregnant?

Creon can be used during pregnancy only when the expected benefit to the mother outweighs any potential risk to the fetus. Because human data are limited, the prescribing clinician should evaluate nutritional needs and consider alternative strategies if appropriate.

How quickly will I notice an improvement after starting Creon?

Many patients report reduced steatorrhea and better tolerance of fatty meals within a few days, but weight gain and normalization of vitamin levels may take several weeks of consistent use.

Do I need to take a vitamin supplement with Creon?

Because pancreatic enzymes can enhance the absorption of fat-soluble vitamins, supplementation is usually not required unless a deficiency has been documented. Periodic blood tests guide any need for additional vitamins.

What should I do if I experience persistent abdominal pain?

Persistent or severe abdominal pain could signal an adverse reaction such as fibrosing colonopathy or an unrelated gastrointestinal condition. Seek medical attention promptly for evaluation.

Can I open the capsule and mix it with food?

Yes. If you have difficulty swallowing, you may open the capsule and sprinkle the granules onto a small amount of acidic soft food (e.g., applesauce). Eat the mixture immediately without chewing to preserve enzyme activity.

Is Creon covered by the NHS?

Creon is listed on the NHS Drug Tariff for the treatment of exocrine pancreatic insufficiency, so it may be prescribed free of charge when clinically indicated. Specific coverage can vary by local Clinical Commissioning Group.

Will antacids reduce the effectiveness of Creon?

Antacids that raise gastric pH can decrease the activation of lipase, potentially lowering the drug’s efficacy. If antacids are needed, administer them at least 2 hours apart from Creon.

How does Creon differ from other pancreatic enzyme products?

All pancreatic enzyme preparations contain similar enzyme ratios, but formulations differ in strength, pill size, and the presence of enteric coating. Creon’s 150 mg capsule is a common medium strength that balances ease of swallowing with dosing flexibility.

Can I travel with Creon on an airplane?

Yes. Creon is not a controlled substance and can be carried in hand luggage. Keep the medication in its original packaging with the label visible, and carry a copy of the prescription in case security asks for verification.

What should I do if I miss a dose for an entire meal?

Do not double the next dose. Instead, take the missed capsule with the following meal and continue the regular dosing schedule. If you are uncertain, contact your prescriber for guidance.

What is Creon?

Creon is a prescription medication used to aid digestion in adults who have exocrine pancreatic insufficiency (EPI).

  • Active ingredient: Pancrelipase - a blend of digestive enzymes (amylase, lipase and proteases).
  • Formulation: Small pills (capsules) each containing 150 mg of pancrelipase.
  • Therapeutic class: Digestive health - pancreatic enzyme replacement therapy.
  • Regulatory status in the UK: Prescription-only medicine (POM) authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).

Pancrelipase replaces enzymes that the pancreas can no longer produce in sufficient amounts, helping the body break down carbohydrates, fats and proteins from food.

How Creon Works in the Body

Pancrelipase supplies three key enzymes that act in the small intestine:

  • Amylase hydrolyses starches into simple sugars.
  • Lipase cleaves dietary fats into free fatty acids and monoglycerides.
  • Proteases (trypsin, chymotrypsin, etc.) break down proteins into peptides and amino acids.

When taken with a meal, the enzymes are released from the capsule, become active in the intestinal lumen, and mimic the normal pancreatic secretions. This restores the normal cascade of digestion, allowing nutrients to be absorbed more efficiently. The onset of action is rapid-enzymatic activity begins as soon as the capsule reaches the duodenum-while the effect persists throughout the duration of the meal.

Conditions Treated by Creon

Creon is approved in the United Kingdom for the management of exocrine pancreatic insufficiency arising from:

  • Cystic fibrosis - a genetic disorder that impairs pancreatic enzyme production.
  • Chronic pancreatitis - long-term inflammation that damages pancreatic tissue.
  • Pancreatic cancer - especially after surgical resection that reduces enzyme output.
  • Pancreatic surgery (e.g., Whipple procedure) - where part of the pancreas has been removed.

The medication is intended for adults (including older adults) who exhibit signs of malabsorption such as steatorrhea, weight loss, or nutritional deficiencies.

Patient Suitability and Contraindications

Who Should Consider Creon?

  • Individuals diagnosed with EPI who experience difficulty gaining or maintaining weight.
  • Patients whose laboratory tests show low serum levels of fat-soluble vitamins (A, D, E, K) secondary to malabsorption.
  • Those who have been advised by a gastroenterology specialist that enzyme supplementation is required.

Absolute Contraindications

  • Known hypersensitivity to pancrelipase, pork protein, or any capsule excipient.
  • Obstructive gastrointestinal disease (e.g., severe gastric outlet obstruction) that prevents the capsule from reaching the small intestine.

Relative Contraindications & Special Populations

  • Pregnancy and lactation: Use only if the expected benefit outweighs potential risk; limited human data are available.
  • Severe liver disease: May affect the metabolism of co-administered drugs; caution is advised.
  • Elderly patients: Start with the lowest effective dose and monitor for tolerance, as renal function may influence drug elimination indirectly.

If any of these conditions apply, a healthcare professional should assess the risks before prescribing Creon.

Safety Profile: Side Effects and Interactions

Common Side Effects

  • Abdominal discomfort (cramps, bloating) - frequently reported and usually mild.
  • Nausea or vomiting - often related to the timing of the dose with food.
  • Diarrhoea or loose stools - may indicate an excess of enzymatic activity.
  • Constipation - can occur when the dose is insufficient for the fat content of a meal.

These symptoms are generally transient and improve with dose adjustment.

Serious Adverse Events

  • Fibrosing colonopathy - a rare, severe narrowing of the colon reported with very high doses of pancreatic enzymes; early signs include persistent abdominal pain and changes in bowel habit.
  • Allergic reactions - ranging from skin rash to anaphylaxis in individuals with pork protein allergy.
  • Pancreatitis - exceedingly uncommon but listed as a potential risk; patients should seek medical attention for severe upper-abdominal pain.

Drug Interactions

  • Antacids and acid-reducing agents (e.g., proton-pump inhibitors, H₂ blockers): Raising gastric pH can reduce the activation of lipase, potentially lowering the therapeutic effect.
  • Bile-acid sequestrants (e.g., cholestyramine, colestipol): May bind pancreatic enzymes and decrease their availability.
  • Orlistat: A lipase inhibitor that can antagonise the action of Creon, leading to reduced fat absorption.

When such agents are required, clinicians often adjust the timing (e.g., spacing doses by at least 2 hours) to minimise interaction.

Food and Lifestyle Interactions

  • Take with meals or snacks: The enzymes act only when food is present; taking Creon on an empty stomach provides little benefit.
  • Alcohol consumption: May irritate the gastrointestinal tract and exacerbate abdominal discomfort.
  • Driving or operating machinery: Creon does not impair cognition, but severe abdominal symptoms could temporarily affect concentration.

Patients should inform their healthcare provider of all prescription medicines, over-the-counter products, supplements and herbal remedies they are using.

How to Take Creon

Standard Dosing

  • Creon is supplied as 150 mg pancrelipase pills.
  • The usual regimen is one capsule with each main meal and half a capsule with each snack.
  • Dosage is highly individualised; clinicians base the total daily number of capsules on the fat content of the diet, body weight, and clinical response (e.g., improvement in stool consistency and weight gain).

Special Populations

  • Renal or hepatic impairment: No specific dose reduction is required, but clinicians monitor for fluid and electrolyte balance.
  • Elderly: Begin with the lowest effective dose and increase slowly if needed.
  • Patients unable to swallow pills: Capsules can be opened and the granules sprinkled on a spoonful of soft, acidic food (e.g., applesauce). The mixture should be swallowed immediately without chewing.

Missed Dose

  • If a meal is missed, do not double the next dose. Instead, take the missed capsule with the next appropriate meal or snack.

Overdose

  • Symptoms are usually limited to excessive abdominal cramping, diarrhoea, or nausea. In severe cases, seek urgent medical care. No specific antidote exists; treatment is supportive.

Discontinuation

  • Creon does not require tapering. However, abrupt cessation may lead to a rapid return of malabsorption symptoms; patients should discuss any changes with their prescriber.

Monitoring and Follow-Up

  • Weight and Body Mass Index (BMI): Recorded at baseline and during follow-up visits to assess nutritional improvement.
  • Stool assessment: Frequency of steatorrhea (fatty stools) helps gauge enzyme adequacy.
  • Vitamin levels: Periodic measurement of fat-soluble vitamins (A, D, E, K) is recommended, especially for long-term users.
  • Liver function tests: May be performed if the patient has underlying hepatic disease.

Regular review, usually every 3-6 months, ensures that the dose remains optimal and that any adverse effects are identified early.

Storage and Handling

  • Store Creon at room temperature (15-30 °C), protected from moisture and direct sunlight.
  • Keep the container tightly closed; avoid exposure to humidity which can degrade the enzymes.
  • Do not freeze the medication.
  • Dispose of unused capsules in accordance with local pharmacy waste guidelines; many UK pharmacies offer medication take-back schemes.

Medication-Specific Glossary

Pancrelipase
A combination of pancreatic enzymes (amylase, lipase, proteases) derived from porcine pancreas, formulated to replace deficient digestive enzymes.
Lipase
The enzyme that hydrolyses triglycerides into free fatty acids and monoglycerides, essential for fat absorption.
Fibrosing colonopathy
A rare, severe narrowing of the colon caused by extremely high doses of pancreatic enzyme preparations; identified by progressive abdominal pain and altered bowel habits.
Exocrine pancreatic insufficiency (EPI)
A condition in which the pancreas does not produce enough digestive enzymes, leading to malabsorption of nutrients.

Medical Disclaimer

This article provides educational information about Creon and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Information for Creon is sourced from established medical standards and updated frequently. It is provided for general guidance and should be confirmed with a healthcare professional before use.
Categories
Hoe kunt u Gezondheid van Vrouwen kopen - Levonorgestrel zonder recept Treatment guide for Respiratory Health: - Buy Fluticasone Salmeterol Hong Kong